Atlas Trials

Utility of the Pharmacogenetic Information Provided by NEUROPHARMAGEN in the Treatment of Bipolar Depressionwith Bipolar Depression

Clinical trial NCT04923204 · COMPLETED

Trial details

NCT number
NCT04923204
Sponsor
AB Biotics, SA
Status
COMPLETED
Study type
OBSERVATIONAL
Bipolar Disorder
Start date
2016-03-01
Primary completion
2016-03-31
Enrollment
76

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.